Last year, IBM announced it would be investing $1 billion in Watson, a cognitive-computing platform, with $100 million being dedicated to find new things for Watson to do. A few days ago, the company announced it would be using the artificial intelligence technology to help diagnose dermatological diseases.
IBM is partnering with Modernizing Medicine, a company which produces medical record-keeping software, to integrate Watson in the package they offer dermatologists. The software, which is expected to be released later this year, is meant to speed-up note-taking and coding in dermatologists' offices. Watson will be available to said offices through an iPad app or web portal.
“We’re continuing to roll out the Watson platform as a very solid ecosystem to build on top of," Claudia Fan Munce, a managing director with IBM’s Venture Capital group, told Fast Company. "As you can imagine, venture is a very strong pipeline to find the best entrepreneurial companies with unique solutions.”
It's expected that IBM will announce other healthcare and retail uses for Watson in the near future.
Learn more about Watson in the video below.